Literature DB >> 8289781

Use of double-replacement gene targeting to replace the murine alpha-lactalbumin gene with its human counterpart in embryonic stem cells and mice.

A Stacey1, A Schnieke, J McWhir, J Cooper, A Colman, D W Melton.   

Abstract

The mouse alpha-lactalbumin gene has been replaced with the human gene by two consecutive rounds of gene targeting in hypoxanthine phosphoribosyltransferase (HPRT)-deficient feeder-independent murine embryonic stem (ES) cells. One mouse alpha-lactalbumin allele was first replaced by an HPRT minigene which was in turn replaced by human alpha-lactalbumin. The end result is a clean exchange of defined DNA fragments with no other DNA remaining at the target locus. Targeted ES cells at each stage remained capable of contributing efficiently to the germ line of chimeric animals. Double replacement using HPRT-deficient ES cells and the HPRT selection system is therefore a powerful and flexible method of targeting specific alterations to animal genes. A typical strategy for future use would be to generate a null mutation which could then be used to produce multiple second-step alterations at the same locus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8289781      PMCID: PMC358456          DOI: 10.1128/mcb.14.2.1009-1016.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus.

Authors:  C Deng; M R Capecchi
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

Review 2.  Manipulating the genome by homologous recombination in embryonic stem cells.

Authors:  A Zimmer
Journal:  Annu Rev Neurosci       Date:  1992       Impact factor: 12.449

3.  Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs.

Authors:  H te Riele; E R Maandag; A Berns
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

4.  A new mouse embryonic stem cell line with good germ line contribution and gene targeting frequency.

Authors:  T M Magin; J McWhir; D W Melton
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

5.  Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells.

Authors:  S Thompson; A R Clarke; A M Pow; M L Hooper; D W Melton
Journal:  Cell       Date:  1989-01-27       Impact factor: 41.582

6.  Location of crossovers during gene targeting with insertion and replacement vectors.

Authors:  C Deng; K R Thomas; M R Capecchi
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

7.  The effects of terminal heterologies on gene targeting by insertion vectors in embryonic stem cells.

Authors:  S Kumar; J P Simons
Journal:  Nucleic Acids Res       Date:  1993-04-11       Impact factor: 16.971

8.  Hoxb-4 (Hox-2.6) mutant mice show homeotic transformation of a cervical vertebra and defects in the closure of the sternal rudiments.

Authors:  R Ramírez-Solis; H Zheng; J Whiting; R Krumlauf; A Bradley
Journal:  Cell       Date:  1993-04-23       Impact factor: 41.582

Review 9.  Modifying the mouse: design and desire.

Authors:  A Bradley; P Hasty; A Davis; R Ramirez-Solis
Journal:  Biotechnology (N Y)       Date:  1992-05

10.  Gene targeting using a mouse HPRT minigene/HPRT-deficient embryonic stem cell system: inactivation of the mouse ERCC-1 gene.

Authors:  J Selfridge; A M Pow; J McWhir; T M Magin; D W Melton
Journal:  Somat Cell Mol Genet       Date:  1992-07
View more
  32 in total

1.  Factors affecting the efficiency of introducing precise genetic changes in ES cells by homologous recombination: tag-and-exchange versus the Cre-loxp system.

Authors:  J C Vazquez; C Nogues; E B Rucker; J A Piedrahita
Journal:  Transgenic Res       Date:  1998-05       Impact factor: 2.788

Review 2.  Modification and repression of genes expressed in the mammary gland using gene targeting and other technologies.

Authors:  J L Vilotte; P L'Huillier; J C Mercier
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-07       Impact factor: 2.673

3.  Pre-selection of integration sites imparts repeatable transgene expression.

Authors:  H Wallace; R Ansell; J Clark; J McWhir
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

4.  Efficient repetitive alteration of the mouse Huntington's disease gene by management of background in the tag and exchange gene targeting strategy.

Authors:  J A Cearley; P J Detloff
Journal:  Transgenic Res       Date:  2001-12       Impact factor: 2.788

5.  Development of the mammary gland requires DGAT1 expression in stromal and epithelial tissues.

Authors:  Sylvaine Cases; Ping Zhou; Jonathan M Shillingford; Bryony S Wiseman; Jo Dee Fish; Christina S Angle; Lothar Hennighausen; Zena Werb; Robert V Farese
Journal:  Development       Date:  2004-05-26       Impact factor: 6.868

Review 6.  Biomedical and agricultural applications of animal transgenesis.

Authors:  Alison J Thomson; Jim McWhir
Journal:  Mol Biotechnol       Date:  2004-07       Impact factor: 2.695

7.  The molecular basis of multiple vector insertion by gene targeting in mammalian cells.

Authors:  P Ng; M D Baker
Journal:  Genetics       Date:  1999-03       Impact factor: 4.562

8.  A gene-targeting approach identifies a function for the first intron in expression of the alpha1(I) collagen gene.

Authors:  S G Hormuzdi; R Penttinen; R Jaenisch; P Bornstein
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 9.  Internal ribosome entry sites and dicistronic RNAs in mammalian transgenesis.

Authors:  P S Mountford; A G Smith
Journal:  Trends Genet       Date:  1995-05       Impact factor: 11.639

10.  Lactation is disrupted by alpha-lactalbumin deficiency and can be restored by human alpha-lactalbumin gene replacement in mice.

Authors:  A Stacey; A Schnieke; M Kerr; A Scott; C McKee; I Cottingham; B Binas; C Wilde; A Colman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.